Hai cercato la traduzione di indicated da Italiano a Danese

indicated to promote
indicated to promote

indicated for the short term treatment of insomnia
n05ch01 indicated for the short term treatment of insomnia

n05ch01 indicated for the short term treatment of insomnia
n05ch01 indicated for the short term treatment of insomnia

b02bd02 indicated for the control and prevention of haemorrhagic episodes
b02bd02 indicated for the control and prevention of haemorrhagic episodes

b01ax indicated in purpura fulminans and coumarin induced skin necrosis in
b01ax

s01gx indicated for the prevention, immediate relief and treatment of the symptoms of allergic conjuctivitis
s01gx indicated for the prevention, immediate relief and treatment of the symptoms of allergic conjuctivitis

sufficient additional information and documents shall be provided to support the information indicated in the claim form .
sufficient additional information and documents shall be provided to support the information indicated in the claim form .

concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction
concept paper on the development of a cpmp note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction

when the earliest debit time indicator is used , the accepted payment order is stored and only entered into the entry disposition at the indicated time .
when the earliest debit time indicator is used , the accepted payment order is stored and only entered into the entry disposition at the indicated time .

(g) the primary objective of the measure, as indicated by the uk authorities, is to promote the regional development.
(g) the primary objective of the measure, as indicated by the uk authorities, is to promote the regional development.

[13] if more than one method is indicated please provide additional details in the "relevant comments" section of this point
[13] if more than one method is indicated please provide additional details in the "relevant comments" section of this point

declares that, except where otherwise clearly indicated, these products are of ... [16] indicazione obbligatoria dell'origine dei prodotti.
declares that, except where otherwise clearly indicated, these products are of ... [16] her angives præferenceoprindelsen.

- reduced duty up to the quantity indicated in sections 17 and 18 of this licence (regulation (ec) no 638/2003)
- reduced duty up to the quantity indicated in sections 17 and 18 of this licence (regulation (ec) no 638/2003)

in inglese reduced duty to eur 88 per tonne up to the quantity indicated in sections 17 and 18 of this licence (regulation (ec) no 327/98)
på engelsk reduced duty to eur 88 per tonne up to the quantity indicated in sections 17 and 18 of this licence (regulation (ec) no 327/98)

adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow-acting anti-rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti-fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications:
adjustment for baseline covariates points to consider on the clinical investigation of medicinal products in the treatment of asthma note for guidance on the clinical investigation of medicinal products for the treatment of urinary incontinence in women note for guidance on the evaluation of medicinal products for treatment of migraine appendix to the cpmp note for guidance on the clinical investigation of medicinal products in the treatment of schizophrenia, on methodology of clinical trials concerning the development of depot preparations of approved medicinal products in schizophrenia note for guidance on the evaluation of medicinal products indicated for thrombolysis in acute myocardial infarction addendum on acute cardiac failure to the cpmp note for guidance on clinical investigation of medicinal products in the treatment of acute cardiac failure note for guidance on the evaluation of medicinal products for the treatment of dyslipoproteinaemia points to consider on clinical investigation of slow- acting anti- rheumatic medicinal products in rheumatoid arthritis points to consider on irritable bowel syndrome points to consider document on the evaluation of new anti- fungal agents for invasive fungal infections points to consider on biostatistical/ methodological issues arising from cpmp discussion on licensing applications: